Drug Shortage Report for TEVA-5 ASA
| Report ID | 145780 |
| Drug Identification Number | 02171929 |
| Brand name | TEVA-5 ASA |
| Common or Proper name | TEVA-5 ASA 400MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MESALAZINE |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL ORAL |
| Packaging size | 500 & 100 |
| ATC code | A07EC |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-09-15 |
| Estimated end date | 2022-04-20 |
| Actual end date | 2022-04-20 |
| Shortage status | Resolved |
| Updated date | 2022-04-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v32 | 2022-04-21 | French | Compare |
| v31 | 2022-04-21 | English | Compare |
| v30 | 2022-03-17 | French | Compare |
| v29 | 2022-03-17 | English | Compare |
| v28 | 2022-03-09 | French | Compare |
| v27 | 2022-03-09 | English | Compare |
| v26 | 2022-03-03 | French | Compare |
| v25 | 2022-03-03 | English | Compare |
| v24 | 2022-02-24 | French | Compare |
| v23 | 2022-02-24 | English | Compare |
| v22 | 2022-02-17 | French | Compare |
| v21 | 2022-02-17 | English | Compare |
| v20 | 2022-01-27 | French | Compare |
| v19 | 2022-01-27 | English | Compare |
| v18 | 2022-01-20 | French | Compare |
| v17 | 2022-01-20 | English | Compare |
| v16 | 2022-01-13 | French | Compare |
| v15 | 2022-01-13 | English | Compare |
| v14 | 2021-12-17 | French | Compare |
| v13 | 2021-12-17 | English | Compare |